{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:59:00Z","timestamp":1772038740537,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.htct.2023.08.007","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T05:05:23Z","timestamp":1698555923000},"page":"428-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of efficacy and safety in the use of cytarabine for mobilization of hematopoietic stem cells in a reference hospital in northeastern Brazil"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1135-4416","authenticated-orcid":false,"given":"Kaio Jos\u00e9 Santos","family":"de Andrade","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6737-1760","authenticated-orcid":false,"given":"Lu\u00eds F\u00e1bio Barbosa","family":"Botelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo Froes","family":"Calixto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela Gomes","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3964-356X","authenticated-orcid":false,"given":"Leina Yukari","family":"Etto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Victor Maia","family":"Loureiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.htct.2023.08.007_bib0001","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00277-015-2557-y","article-title":"Increased efficacy of intermediate-dose cytarabine + G-CSF compared to DHAP + G-CSF for stem cell mobilization in patients with lymphoma: an analysis by the Polish lymphoma research group","volume":"95","author":"Giebel","year":"2016","journal-title":"Ann Hematol"},{"issue":"7","key":"10.1016\/j.htct.2023.08.007_bib0002","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/bmt.2014.39","article-title":"Autologous haematopoietic stem cell mobilization in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation","volume":"49","author":"Mohty","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.htct.2023.08.007_bib0003","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2141.2010.08313.x","article-title":"Current status of stem cell mobilization: review","volume":"150","author":"Gertz","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.htct.2023.08.007_bib0004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.critrevonc.2015.04.009","article-title":"Is peripheral blood or bone marrow a better source of stem cells for transplantation in cases of HLA-matched unrelated donors? A meta-analysis","volume":"96","author":"Wu","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.htct.2023.08.007_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tmrv.2018.11.003","article-title":"Peripheral blood or bone marrow stem cells? Practical considerations in hematopoietic stem cell transplantation","volume":"33","author":"Amouzegar","year":"2019","journal-title":"Transfus Med Rev [Internet]"},{"issue":"23","key":"10.1016\/j.htct.2023.08.007_bib0006","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1182\/blood-2008-08-174946","article-title":"Plerixafor, and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma","volume":"113","author":"DiPersio","year":"2009","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.htct.2023.08.007_bib0007","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.bbmt.2012.01.008","article-title":"Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies","volume":"18","author":"Sheppard","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.htct.2023.08.007_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-022-02802-6","article-title":"Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials","volume":"13","author":"Luo","year":"2022","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"10.1016\/j.htct.2023.08.007_bib0009","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/bmt.2012.269","article-title":"Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted by mobilizers","volume":"48","author":"Giebel","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.htct.2023.08.007_bib0010","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/bmt.2011.82","article-title":"Proposed definition of \u201cpoor mobilizer\u201d in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Italian Bone Marrow Transplant Group","volume":"47","author":"Olivieri","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"September","key":"10.1016\/j.htct.2023.08.007_bib0011","doi-asserted-by":"crossref","first-page":"ix353","DOI":"10.1016\/S0923-7534(20)33638-3","article-title":"Very high efficacy of cytarabine + G-CSF compared to cyclophosphamide + G-CSF as hematopoietic stem cell mobilization in patients with lymphoid malignancies referred for autologous transplantation","volume":"23","author":"Kruzel","year":"2012","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.htct.2023.08.007_bib0012","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/trf.12906","article-title":"Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure","volume":"55","author":"Calder\u00f5n-Cabrera","year":"2015","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.htct.2023.08.007_bib0013","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/bmt.2015.23","article-title":"G-CSF plus preemptive plerixafor vs hyperfractionated CY plus G-CSF for autologous stem cell mobilization in multiple myeloma: effectiveness, safety, and cost analysis","volume":"50","author":"Antar","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.htct.2023.08.007_bib0014","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V98.7.2059","article-title":"Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation","volume":"98","author":"Narayanasami","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.htct.2023.08.007_bib0016","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00277-021-04427-w","article-title":"Correction to: comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis (Annals of Hematology, (2021), 100, 2, (563-573), 10,100","volume":"100","author":"Wang","year":"2021","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.htct.2023.08.007_bib0017","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.bmt.1700867","article-title":"Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone","volume":"20","author":"Alegre","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.htct.2023.08.007_bib0018","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.bbmt.2018.09.023","article-title":"Increased efficacy of stem cell chemomobilization with intermediate-dose cytarabine plus granulocyte colony-stimulating factor (G-CSF) compared with G-CSF alone in patients with multiple myeloma: results of a randomized trial","volume":"25","author":"Czerw","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.htct.2023.08.007_bib0019","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41409-018-0396-x","article-title":"Cytarabine + G-CSF is more effective than cyclophosphamide + G-CSF as a stem cell mobilization regimen in multiple myeloma","volume":"54","author":"Jelinek","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.htct.2023.08.007_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12185-012-1135-5","article-title":"Very high efficacy of intermediate-dose cytarabine in combination with G-CSF as a second-line mobilization of hematopoietic stem cells","volume":"96","author":"Kruzel","year":"2012","journal-title":"Int J Hematol"},{"issue":"4","key":"10.1016\/j.htct.2023.08.007_bib0021","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jca.21784","article-title":"Higher efficacy of intermediate dose cytarabine + G-CSF compared to cyclophosphamide + G-CSF in hematopoietic stem cell mobilization in patients with multiple myeloma","volume":"35","author":"Bogucka-Fedorczuk","year":"2020","journal-title":"J Clin Apher"},{"issue":"3","key":"10.1016\/j.htct.2023.08.007_bib0022","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.transci.2019.03.018","article-title":"Intermediate-dose cytarabine plus G-CSF as mobilization regimen for newly diagnosed multiple myeloma and heavily pre-treated patients with hematological and non-hematological malignancies","volume":"58","author":"Callera","year":"2019","journal-title":"Transfus Apher Sci"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923025804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923025804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T22:37:14Z","timestamp":1726612634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137923025804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2531137923025804"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2023.08.007","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of efficacy and safety in the use of cytarabine for mobilization of hematopoietic stem cells in a reference hospital in northeastern Brazil","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2023.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}